Vimarsana
Biggest News Aggregation in the World

Page 10 - Guy Bennett News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Guy Bennett. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Guy Bennett Today - Breaking & Trending Today

But Is It Concrete? by Lucy Ives | Poetry Foundation - Vimarsana News

But Is It Concrete? by Lucy Ives | Poetry Foundation

Art by Matt Chase. The law of imitative representation, aka mimesis, reigned supreme in Western art for so long that its resistors sometimes found it hard to stop battling it, even when and where it had lost its grip. Consider, for example, some responses to so-called concrete poetry on the part of advocates of so-called conceptual art. The writer and critic Lucy Lippard differentiates between concrete poetry’s naive strategies of linguistic resemblance “where the words are made to look like something, an image” and conceptualism’s more sophisticated li...

Let's get one thing straight – if an actor is good enough, their sexuality shouldn't matter - Vimarsana News

Let's get one thing straight – if an actor is good enough, their sexuality shouldn't matter

Let’s get one thing straight – if an actor is good enough, their sexuality shouldn't matter Russell T Davies wants only gay actors to play gay roles. But that would be bad news for all actors 12 January 2021 • 3:44pm James Corden's turn in The Prom, says Tim Robey, is more 'crude stereotype' than deft acting Credit: Netflix I’d never used the term “gayface” until recently, when it served as shorthand for James Corden’s cringeworthy comic performance in Netflix's The Prom. That film is painful in general, but Corden is the absolute chief of what’s bad about it. Playing a washe...

Medexus (MDP.V) expands specialty pharmaceuticals portfolio - Vimarsana News

Medexus (MDP.V) expands specialty pharmaceuticals portfolio

VANCOUVER, BC, Dec. 20, 2020 /CNW/ - Medexus Pharmaceuticals (MDP.V) is a specialty pharmaceuticals company that delivers innovative medicines to underserved segments of the market. With over 20,000 prescription drug products approved for marketing in North America, the pharmacology space is fiercely competitive. Identifying "underserved markets" requires scientific, regulatory and business savvy.  Medexus' CEO Ken d'Entremont – a chemist by trade - is the former V.P of business development at Big Pharma company Sanofi, where he led the in-licensing initiatives for Sanofi Canada. The cu...